AKT1 and cancer: In LoVo cells, Hsu and colleagues [13] reported that TQ (5, 10, and 20 μM) suppressed the expression of proteins critical for cancer progression, including COX-2, PI3K, AKT, and glycogen synthase kinase-3 beta (GSK-3β), with the strongest reduction observed at 20 μM.